Full Text View
Tabular View
No Study Results Posted
Related Studies
Insulin-like Growth Factor-1 (IGF-1) in Amyotrophic Lateral Sclerosis (ALS) Trial
This study has been completed.
Study NCT00035815   Information provided by Mayo Clinic
First Received: May 6, 2002   Last Updated: July 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amyotrophic Lateral Sclerosis
Additional conditions recognized in this trial
Motor Neuron Disease
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Pathologic Processes
Spinal Cord Diseases
Additional drug interventions recognized in this trial
Insulin
Mitogens
More general drug interventions related to this trial
Hypoglycemic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services